260 results on '"Galalae, Razvan"'
Search Results
2. The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change
3. Preliminary results of adjuvant image-guided vaginal brachytherapy alone for early stage endometrial carcinoma
4. The association of vagina equivalent dose in 2Gy fraction (EQD2) to late vagina toxicity in patients of cervical cancer treated with WPRT plus IGABT
5. Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale
6. Ultrasound-Guided Brachytherapy for Cervical Cancer - A Tool for Quality Improvement in Brachytherapy?
7. Psychometric validation of the European Organisation for Research and Treatment of Cancer–Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22)
8. Comparison of clinical outcomes achieved with image-guided adaptive brachytherapy for cervix cancer using CT or transabdominal ultrasound
9. The impact of curative cancer treatment on sexual health – clinical results from the EORTC QLQ-SH22 validation study.
10. Hyaluronic acid gel injection in rectovaginal septum reduced incidence of rectal bleeding in brachytherapy for gynecological malignancies
11. The Value of PET/CT in Particle Therapy Planning of Various Tumors with SSTR2 Receptor Expression: Comparative Interobserver Study
12. Radical dose escalation by high-dose-rate brachytherapy for localized prostate cancer—Significance of prostate-specific antigen nadir level within 18 months as correlation for long-term biochemical control
13. ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost – GEC-ESTRO Breast Cancer Working Group practical recommendations
14. Intermediate-term results of trans-abdominal ultrasound (TAUS)-guided brachytherapy in cervical cancer
15. Risk factors and state-of-the-art indications for boost irradiation in invasive breast carcinoma
16. Two-year results of transabdominal ultrasound-guided brachytherapy for cervical cancer
17. The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer—A benchmark for high-tech external beam radiotherapy alone?
18. Ten-year outcomes for prostate cancer patients with Gleason 8 through 10 treated with external beam radiation and high-dose-rate brachytherapy boost in the PSA era
19. Intermediate-term results of image-guided brachytherapy and high-technology external beam radiotherapy in cervical cancer: Chiang Mai University experience
20. Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review
21. Deep inspiration breath-hold (DIBH) radiotherapy in left-sided breast cancer: Dosimetrical comparison and clinical feasibility in 20 patients
22. Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes
23. Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)
24. Brachytherapy dose changes: comparing in-room and out-room image-guided brachytherapy. A randomized study
25. International validation of the revised European Organisation for Research and treatment of cancer head and neck cancer module, the EORTC QLQ-HN43
26. The Value of SSTR2 Receptor-Targeted PET/CT in Proton Irradiation of Grade I Meningioma
27. Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale
28. Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database
29. 20 Years of Experience in Static Intensity-Modulated Total-Body Irradiation and Lung Toxicity: Results in 257 Consecutive Patients
30. Hypofractionated Conformal HDR Brachytherapy in Hormone Naïve Men with Localized Prostate Cancer: Is Escalation to Very High Biologically Equivalent Dose Beneficial in All Prognostic Risk Groups?
31. Validation of the German prostate-specific module
32. Significant Negative Impact of Adjuvant Chemotherapy on Health-Related Quality of Life (HR-QoL) in Women with Breast Cancer Treated by Conserving Surgery and Postoperative 3-D Radiotherapy: A Prospective Measurement
33. Health-Related Quality of Life Measurement in Long-Term Survivors and Outcome Following Radical Radiotherapy for Localized Prostate Cancer
34. CT-guided lymphoscintigraphy in patients with squamous cell carcinoma of the head and neck: a feasibility study
35. Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy — Update of the EORTC QLQ-H&N35, Phase I
36. Low-Dose-Whole-Lung Radiotherapy for Older Patients with Coronavirus Disease (Covid-19) Pneumonia: A Phase I-II Prospective Non-Randomized Protocol by the International Geriatric Radiotherapy Group
37. Low dose whole lung radiotherapy for older patients with corona virus 19 disease (COVID-19) pneumonitis: practical protocol by the International Geriatric Radiotherapy Group (Preprint)
38. RIG-1-Like Receptor Activation Synergizes With Intratumoral Alpha Radiation to Induce Pancreatic Tumor Rejection, Triple-Negative Breast Metastases Clearance, and Antitumor Immune Memory in Mice
39. Accelerated partial breast irradiation by brachytherapy: present evidence and future developments
40. Feasibility and preliminary outcome of salvage combined HDR brachytherapy and external beam radiotherapy (EBRT) for local recurrences after radical prostatectomy
41. Fractionated perineal high-dose-rate temporary brachytherapy combined with external beam radiation in the treatment of localized prostate cancer: is lymph node sampling necessary?
42. Eine schnelle Bildkorrelationsmethode zur Überprüfung der Patientenlagerung in der Strahlentherapie
43. No Apparent Benefit at 5 Years From a Course of Neoadjuvant/Concurrent Androgen Deprivation for Patients With Prostate Cancer Treated With a High Total Radiation Dose
44. Early results of localised, high-risk prostate cancer treated by moderate hypo-fractionation (70 Gy at 2·5 Gy per fraction): 5-year experiences of a moderate hypo-fractionation regimen
45. Immunomodulation of the Antitumor Response Induced by Alpha Radiation-Based Brachytherapy Results in the Elimination of Spontaneous Lung Metastases in a Triple Negative Breast Cancer Mice Model and in the Cure of Colon Cancer Bearing Mice
46. Is standard breast-conserving therapy (BCT) in elderly breast cancer patients justified? A prospective measurement of acute toxicity according CTC-classification
47. Early results of localised, high-risk prostate cancer treated by moderate hypo-fractionation (70 Gy at 2·5 Gy per fraction): 5-year experiences of a moderate hypo-fractionation regimen.
48. Proof of Very Low Acute/Chronic Toxicity of Postoperative (Breast-conserving Surgery) APBI by Interstitial Multicatheter High-Dose-Rate Brachytherapy for Early Breast Cancer (BC) - One-Year Outcomes of a Prospective Assessment Study in 77 Patients
49. Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer
50. Salvage high-dose-rate brachytherapy for prostate cancer persistence after brachytherapy: repeated use of a polyethylene glycol hydrogel spacer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.